Delegation of Authority, 81479 [2020-27606]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 242 / Wednesday, December 16, 2020 / Notices
Dated: December 10, 2020.
Marquita Cullom,
Associate Director.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2020–27589 Filed 12–15–20; 8:45 am]
BILLING CODE 4160–90–P
National Cancer Institute; Notice of
Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Office of the Secretary
Delegation of Authority
Notice is hereby given that I have
delegated to the National Coordinator
for Health Information Technology,
Office of the National Coordinator for
Health Information Technology (ONC),
or his or her successor, the authorities
that are vested in the Secretary of Health
and Human Services under title III,
Section 307, ‘‘International
Cooperation,’’ of the Public Health
Service (PHS) Act, [42 U.S.C. 242 l], as
amended, with regard to participating
with other countries in cooperative
endeavors.
Limitation
This delegation of authority may be
re-delegated within ONC. Previous
delegations and re-delegations made to
officials within the Department of
Health and Human Services for
authorities under Section 307 of the
PHS Act continue in effect. Exercise of
this authority shall be in accordance
with established policies, procedures,
guidelines, and regulations as
prescribed by the Secretary. The
Secretary retains the authority to submit
reports to Congress, promulgate
regulations, and to establish advisory
committees and councils and appoint
their members. I hereby affirm and ratify
any actions taken by the National
Coordinator, ONC, or other ONC
officials, which involve the exercise of
this authority prior to the effective date
of this delegation.
Effective Date
This delegation of authority is
effective immediately.
khammond on DSKJM1Z7X2PROD with NOTICES
Authority
Section 6 of the Reorganization Plan
No. 1 of 1953 and Section 2 of the
Reorganization Plan No. 3 of 1966.
Dated: December 9, 2020.
Eric D. Hargan,
Deputy Secretary.
[FR Doc. 2020–27606 Filed 12–15–20; 8:45 am]
BILLING CODE 4150–45–P
VerDate Sep<11>2014
17:58 Dec 15, 2020
Jkt 253001
Name of Committee: National Cancer
Institute Special Emphasis Panel; K22
Transition Career Development Award.
Date: January 19, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W234, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Adriana Stoica, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W234, Rockville, Maryland 20850,
240–276–6368, Stoicaa2@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Assay
Validation of High-Quality Markers for
Clinical Studies in Cancer.
Date: January 21, 2021.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W124, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Eun Ah Cho, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W124, Rockville,
Maryland 20850, 240–276–6342 choe@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Applications related to Pediatrics.
Date: January 26, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
81479
7W530, Rockville, Maryland 20850,
(Telephone Conference Call).
Contact Person: Shamala K. Srinivas,
Ph.D., Associate Director, Office of Referral,
Review, and Program Coordination, Division
of Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W530, Rockville, Maryland 20850,
240–276–6442 ss537t@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; TEP–3:
SBIR Contract Review.
Date: January 29, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W254, Rockville, Maryland 20850,
(Telephone Conference Call).
Contact Person: Eduardo Emilio Chufan,
Ph.D., Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W254, Rockville, Maryland
20850, 240–276–7975 chufanee@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–5: NCI
Clinical and Translational R21 and Omnibus
R03 Review.
Date: February 4–5, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W248, Rockville, Maryland 20850,
(Telephone Conference Call).
Contact Person: Shree Ram Singh, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W248, Rockville,
Maryland 20817, 240–672–6175 singhshr@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–2: NCI
Clinical and Translational R21 and Omnibus
R03 Review.
Date: February 4–5, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W264, Rockville, Maryland 20850
(Telephone Conference Call)
Contact Person: Ombretta Salvucci, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W264, Rockville,
Maryland 20854, 240–276–7286 salvucco@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI SPORE
(P50) Review IV.
Date: February 9–10, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
E:\FR\FM\16DEN1.SGM
16DEN1
]]>Agencies
[Federal Register Volume 85, Number 242 (Wednesday, December 16, 2020)]
[Notices]
[Page 81479]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-27606]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Delegation of Authority
Notice is hereby given that I have delegated to the National
Coordinator for Health Information Technology, Office of the National
Coordinator for Health Information Technology (ONC), or his or her
successor, the authorities that are vested in the Secretary of Health
and Human Services under title III, Section 307, ``International
Cooperation,'' of the Public Health Service (PHS) Act, [42 U.S.C. 242
l], as amended, with regard to participating with other countries in
cooperative endeavors.
Limitation
This delegation of authority may be re-delegated within ONC.
Previous delegations and re-delegations made to officials within the
Department of Health and Human Services for authorities under Section
307 of the PHS Act continue in effect. Exercise of this authority shall
be in accordance with established policies, procedures, guidelines, and
regulations as prescribed by the Secretary. The Secretary retains the
authority to submit reports to Congress, promulgate regulations, and to
establish advisory committees and councils and appoint their members. I
hereby affirm and ratify any actions taken by the National Coordinator,
ONC, or other ONC officials, which involve the exercise of this
authority prior to the effective date of this delegation.
Effective Date
This delegation of authority is effective immediately.
Authority
Section 6 of the Reorganization Plan No. 1 of 1953 and Section 2 of
the Reorganization Plan No. 3 of 1966.
Dated: December 9, 2020.
Eric D. Hargan,
Deputy Secretary.
[FR Doc. 2020-27606 Filed 12-15-20; 8:45 am]
BILLING CODE 4150-45-P
